Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PLX | AMGN | GILD | CELG | ILMN |
| Company | Protalix Biotherapeutics | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Illumina Inc |
| Price Information | |||||
| Exchange | NYSE Arca | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 1.1900 | 265.72 | 65.50 | 108.01 | 119.65 |
| High | 1.1900 | 270.23 | 66.19 | 108.59 | 120.27 |
| Low | 1.1900 | 265.72 | 65.05 | 107.27 | 118.97 |
| Last | 1.1700 | 269.46 | 65.29 | 108.24 | 121.65 |
| Change | -0.0100 | +0.08 | +0.02 | +0.11 | +0.60 |
| % Change | -0.85% | +0.03% | +0.03% | +0.10% | +0.50% |
| Volume | 247 | 50,443 | 816,564 | 191,230,496 | 15,082 |
| 20-Day Average Volume | 335,610 | 2,036,908 | 6,455,781 | 16,188,930 | 1,470,770 |
| Previous Close | 1.1800 | 269.38 | 65.27 | 108.13 | 121.05 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.2065 | 269.99 | 68.32 | 108.17 | 124.72 |
| 20-Day Raw Stochastic | 34.62% | 39.95% | 10.68% | 63.25% | 15.14% |
| 20-Day Relative Strength | 42.10% | 45.45% | 32.06% | 64.69% | 40.43% |
| Weighted Alpha | -48.68 | +9.44 | -22.67 | +46.30 | -39.85 |
| Today's Opinion | 100% Sell | 72% Sell | 100% Sell | 100% Buy | 88% Sell |
| Previous Opinion | 96% Sell | 72% Sell | 100% Sell | 100% Buy | 88% Sell |
| Last Month's Opinion | 100% Sell | 40% Buy | 88% Sell | 100% Buy | 8% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.42% since 04/18/24 | +0.38% since 04/19/24 | -1.25% since 04/19/24 | -1.97% since 11/13/19 | +1.49% since 04/19/24 |
| Low | 1.1000 on 04/19/24 | 265.72 on 04/26/24 | 65.05 on 04/26/24 | 107.27 on 11/20/19 | 116.91 on 04/25/24 |
| High | 1.2400 on 04/23/24 | 274.86 on 04/24/24 | 67.90 on 04/25/24 | 110.53 on 11/14/19 | 125.70 on 04/23/24 |
| 1-Month | |||||
| %Chg | -3.28% since 03/25/24 | -4.19% since 03/26/24 | -8.96% since 03/26/24 | +5.14% since 10/18/19 | -10.93% since 03/26/24 |
| Low | 1.0900 on 04/18/24 | 260.68 on 04/19/24 | 65.05 on 04/26/24 | 102.40 on 10/21/19 | 115.73 on 04/18/24 |
| High | 1.3500 on 04/09/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 110.70 on 11/13/19 | 140.07 on 03/28/24 |
| 3-Month | |||||
| %Chg | -21.85% since 01/25/24 | -13.41% since 01/26/24 | -17.10% since 01/26/24 | +13.63% since 08/20/19 | -15.25% since 01/26/24 |
| Low | 1.0900 on 04/18/24 | 260.68 on 04/19/24 | 65.05 on 04/26/24 | 93.41 on 08/23/19 | 115.73 on 04/18/24 |
| High | 1.6800 on 03/01/24 | 329.72 on 02/05/24 | 80.00 on 01/29/24 | 110.70 on 11/13/19 | 148.19 on 01/31/24 |
| 6-Month | |||||
| %Chg | -22.37% since 10/25/23 | +0.09% since 10/26/23 | -16.02% since 10/26/23 | +14.14% since 05/20/19 | +6.76% since 10/26/23 |
| Low | 1.0900 on 04/18/24 | 249.70 on 10/31/23 | 65.05 on 04/26/24 | 89.08 on 07/23/19 | 89.00 on 11/10/23 |
| High | 1.9000 on 12/26/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 110.70 on 11/13/19 | 148.19 on 01/31/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 86,201 | 144,488,960 | 81,266,176 | 77,035,920 | 19,277,818 |
| Shares Outstanding, K | 73,052 | 536,376 | 1,245,077 | 711,714 | 159,255 |
| Annual Sales | 65,490,000 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 4,504,000,000 |
| Annual Net Income | 8,310,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | -1,161,000,000 |
| Last Quarter Sales | 10,490,000 | 8,196,000,000 | 7,114,000,000 | 4,520,000,000 | 1,122,000,000 |
| Last Quarter Net Income | -6,040,000 | 767,000,000 | 1,429,000,000 | 1,691,000,000 | -176,000,000 |
| 60-Month Beta | 0.88 | 0.58 | 0.19 | 1.41 | 1.19 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.07 on 03/14/24 | 4.71 on 02/06/24 | -1.32 on 04/25/24 | 2.99 on 10/31/19 | 0.14 on 02/08/24 |
| Latest Earnings Date | 05/02/24 | 05/02/24 | 04/25/24 | 10/31/19 | 05/02/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 24.20 | 14.64 | 9.98 | 10.99 | 141.23 |